{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:31:49Z","timestamp":1789716709612,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11060-017-2643-1","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T05:05:50Z","timestamp":1510722350000},"page":"189-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma"],"prefix":"10.1007","volume":"136","author":[{"given":"Iris","family":"Fried","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Ben Ami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Dvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam Weil","family":"Ben Arush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Postovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed","family":"Abu Kuidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Yalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mony","family":"Benifla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"2643_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/2011.4.JNS101172","volume":"115","author":"I Yang","year":"2011","unstructured":"Yang I, Han SJ, Sughrue ME, Tihan T, Parsa AT (2011) Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J Neurosurg 115:505\u2013511. doi: 10.3171\/2011.4.JNS101172","journal-title":"J Neurosurg"},{"key":"2643_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241\u2013248","journal-title":"Lancet Oncol"},{"key":"2643_CR3","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1016\/j.ejca.2013.08.006","volume":"49","author":"S Bailey","year":"2013","unstructured":"Bailey S, Howman A, Wheatley K, Wherton D, Boota N, Pizer B, Fisher D, Kearns P, Picton S, Saran F et al (2013) Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy: results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer 49:3856\u20133862. doi: 10.1016\/j.ejca.2013.08.006","journal-title":"Eur J Cancer"},{"key":"2643_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, Pollack IF (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children\u2019s Oncology Group. Neuro Oncol 13:410\u2013416. doi: 10.1093\/neuonc\/noq205","journal-title":"Neuro Oncol"},{"key":"2643_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2217\/cns.14.47","volume":"3","author":"EC Kaye","year":"2014","unstructured":"Kaye EC, Baker JN, Broniscer A (2014) Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis. CNS Oncol 3:421\u2013431. doi: 10.2217\/cns.14.47","journal-title":"CNS Oncol"},{"key":"2643_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jneuroim.2013.08.013","volume":"264","author":"J Kmiecik","year":"2013","unstructured":"Kmiecik J, Poli A, Brons NH, Waha A, Eide GE, Enger PO, Zimmer J, Chekenya M (2013) Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. J Neuroimmunol 264:71\u201383. doi: 10.1016\/j.jneuroim.2013.08.013","journal-title":"J Neuroimmunol"},{"key":"2643_CR7","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","volume":"19","author":"O Bloch","year":"2013","unstructured":"Bloch O, Crane CA, Kaur R, Safaee M, Rutkowski MJ, Parsa AT (2013) Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res 19:3165\u20133175. doi: 10.1158\/1078-0432.CCR-12-3314","journal-title":"Clin Cancer Res"},{"key":"2643_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","volume":"86","author":"J Zeng","year":"2013","unstructured":"Zeng J, See AP, Phallen J, Jackson CM, Belcaid Z, Ruzevick J, Durham N, Meyer C, Harris TJ, Albesiano E et al (2013) Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys 86:343\u2013349. doi: 10.1016\/j.ijrobp.2012.12.025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2643_CR9","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1158\/1078-0432.CCR-14-0820","volume":"20","author":"MG Castro","year":"2014","unstructured":"Castro MG, Baker GJ, Lowenstein PR (2014) Blocking immunosuppressive checkpoints for glioma therapy: the more the Merrier! Clin Cancer Res 20:5147\u20135149. doi: 10.1158\/1078-0432.CCR-14-0820","journal-title":"Clin Cancer Res"},{"key":"2643_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-204","volume":"15","author":"JR Westin","year":"2014","unstructured":"Westin JR, Chu F, Zhang M, Fayad LE, Kwak LW, Fowler N, Romaguera J, Hagemeister F, Fanale M, Samaniego F et al (2014) Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Lancet Oncol 15:69\u201377. doi: 10.1016\/S1470-204","journal-title":"Lancet Oncol"},{"key":"2643_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1053\/j.seminoncol.2015.02.008","volume":"42","author":"B Moreno","year":"2015","unstructured":"Moreno B, Parisi G, Robert L, Ribas A (2015) Anti-PD-1 therapy in melanoma. Seminoncology 42:466. doi: 10.1053\/j.seminoncol.2015.02.008","journal-title":"Seminoncology"},{"key":"2643_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nou104","volume":"17","author":"MH Jansen","year":"2015","unstructured":"Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, van der Hoeven EJ, Gidding CE, de Bont ES, Eshghi OS et al (2015) Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 17:160\u2013166. doi: 10.1093\/neuonc\/nou104","journal-title":"Neuro Oncol"},{"key":"2643_CR13","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1158\/1078-0432.CCR-07-4079","volume":"14","author":"R Berger","year":"2008","unstructured":"Berger R, Rotem-Yehudar R, Slama G, Landes S, Kneller A, Leiba M, Koren-Michowitz M, Shimoni A, Nagler A (2008) Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res 14:3044\u20133051. doi: 10.1158\/1078-0432.CCR-07-4079","journal-title":"Clin Cancer Res"},{"key":"2643_CR14","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1200\/JCO.2012.48.3685","volume":"31","author":"P Armand","year":"2013","unstructured":"Armand P, Nagler A, Weller EA, Devine SM, Avigan DE, Chen YB, Kaminski MS, Holland HK, Winter JN, Mason JR et al (2013) Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B cell lymphoma: results of an international phase II trial. J Clin Oncol 31:4199\u20134206. doi: 10.1200\/JCO.2012.48.3685","journal-title":"J Clin Oncol"},{"key":"2643_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/neuonc\/nou307","volume":"17","author":"AS Berghoff","year":"2015","unstructured":"Berghoff AS, Kiesel B, Widhalm G, Rajky O, Ricken G, Wohrer A, Dieckmann K, Filipits M, Brandstetter A, Weller M et al (2015) Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. Neuro Oncol 17:1064\u20131075. doi: 10.1093\/neuonc\/nou307","journal-title":"Neuro Oncol"},{"key":"2643_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2217\/fon.14.20","volume":"10","author":"S Dixit","year":"2014","unstructured":"Dixit S (2014) Immunotherapy for high-grade glioma. Future Oncol 10:911\u2013915. doi: 10.2217\/fon.14.20","journal-title":"Future Oncol"},{"key":"2643_CR17","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V126.23.1838.1838","volume":"126","author":"Y Efebera","year":"2015","unstructured":"Efebera Y, Rosko A, Hofmeister C, Benner J, Bakan C, Stamper K, Lamb T, Hollie D, Sell M, Avigan D et al (2015) First interim results of a phase I\/II study of lenalidomide in combination with anti-PD-1 monoclonal antibody MDV9300 (CT-011) in patients with relapsed\/refractory multiple myeloma. Blood 126:1838","journal-title":"Blood"},{"key":"2643_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/2326-6066.CIR-14-0069","volume":"2","author":"C Tang","year":"2014","unstructured":"Tang C, Wang X, Soh H, Seyedin S, Cortez MA, Krishnan S, Massarelli E, Hong D, Naing A, Diab A et al (2014) Combining radiation and immunotherapy: a new systemic therapy for solid tumors? Cancer Immunol Res 2:831\u2013838. doi: 10.1158\/2326-6066.CIR-14-0069","journal-title":"Cancer Immunol Res"},{"key":"2643_CR19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2217\/imt.15.65","volume":"7","author":"SN Seyedin","year":"2015","unstructured":"Seyedin SN, Schoenhals JE, Lee DA, Cortez MA, Wang X, Niknam S, Tang C, Hong DS, Naing A, Sharma P et al (2015) Strategies for combining immunotherapy with radiation for anticancer therapy. Immunotherapy 7:967\u2013980. doi: 10.2217\/imt.15.65","journal-title":"Immunotherapy"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2643-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2643-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2643-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T21:31:47Z","timestamp":1603315907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2643-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2643"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2643-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,15]]}}}